2 Growth Stocks I'd Buy on the Dip
With the third quarter of 2023 rapidly coming to a close, U.S. equities have turned decidedly volatile over the past few trading sessions. While the exact cause of this turmoil isn't altogether clear, there is a good chance that a lot of it stems from institutional and high net-worth investors rebalancing their portfolios ahead of the start of Q4.
Which stocks stand out as compelling buys on this recent weakness? For my money, I like both Acadia Pharmaceuticals (NASDAQ: ACAD) and Tilray Brands (NASDAQ: TLRY) at current levels. Both companies are long-term growth plays to be sure, but their respective upside potentials could be considerable, to put it mildly. Here's why bargain hunters might want to catch these two falling knives.
Image source: Getty Images.
Source Fool.com
